Lonza EasyDiff supplements for bone marrow CD34+

Friday, 22 July, 2011 | Supplied by: Capsugel Australia Pty Ltd

Lonza EasyDiff supplements for bone marrow CD34+

Primary human bone marrow hematopoietic progenitors are multipotent cells that can differentiate into several lineages. EasyDiff supplements allow differentiation of CD34+ cells into three different hematopoietic lineages (myeloid, erythroid and megakaryocytic) in 96-well plates.

Users simply add the appropriate volume of media (LGM-3 or IMDM) to dilute the supplement and mix with CD34+ cells in media. Once plated into 96-well plates differentiation will be complete in 10-12 days.

There is no need for methylcellulose or any substrate. Users can verify differentiation via quantification of the expression of lineage-specific markers.

The supplements are suitable for both drug discovery and toxicology research.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

Antibodies Inc recombinant antibodies

Recombinant chimeric antibodies are designed to offer several advantages beyond easy multiplexing.

Bioss Multiplex Fluorescent IHC Staining Kit

The Bioss Multiplex Fluorescent (5 Colors) IHC Staining Kit enables the simultaneous detection of...

AdipoGen immune checkpoint reagents for immuno-oncology research

AdipoGen Life Sciences offers a broad panel of immune checkpoint reagents, including recombinant...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd